Resources

Discover how Adimab’s scientific advances are shaping the future of antibody discovery. These resources are designed to inform, inspire, and advance your understanding of our platform.

Featured resource

Novel Anti-CD3 Heavy Chain-Only Antibodies for Use in T Cell-Engaging Therapeutics
Posters

Novel Anti-CD3 Heavy Chain-Only Antibodies for Use in T Cell-Engaging Therapeutics

Llama-derived CD3 VHHs enable simpler, modular T cell engager design with strong functional activity

Download

Filters

Resources

Therapeutic Area

Capabilities

Resources
Benchmarking Antibody-Antigen Co-Folding on Human Monomeric Antigens loading="lazy">
Mon 24 Aug 2026
Publications

Benchmarking Antibody-Antigen Co-Folding on Human Monomeric Antigens

An evaluation of the performance of various co-folding methods for predicting antibody-antigen interactions
Engineering Assembly and Low pH Hold Stress of Anti-CD3 scFv-Based Multispecific T Cell Engagers loading="lazy">
Mon 20 Jul 2026
Posters

Engineering Assembly and Low pH Hold Stress of Anti-CD3 scFv-Based Multispecific T Cell Engagers

Thermal pressuring of an anti-CD3 scFv in Adimab's yeast platform yields stabilizing mutations for T cell engagers
Robust Heavy Chain-Light Chain Pairing Solutions for Generating Clinical Bi- and Multispecifics loading="lazy">
Thu 4 Jun 2026
Posters

Robust Heavy Chain-Light Chain Pairing Solutions for Generating Clinical Bi- and Multispecifics

Engineered HC–LC interfaces direct correct chain pairing, enabling high-purity multispecific antibodies
Anti-TCR Single Domain Antibodies loading="lazy">
Thu 4 Jun 2026
Posters

Potent T Cell-Engaging (TCE) Single-Domain Antibodies that Cross-React with Non-Human Primate (NHP) T Cell Receptor (TCR) Constant Region αβ as an Alternative to CD3 Engagement

TCR-targeting VHHs enable orthogonal T cell activation with strong cytotoxicity and species cross-reactivity
Schematic of Chain Exchange reaction to generate bispecific antibody loading="lazy">
Wed 3 Jun 2026
White papers

Chain Exchange Technology: Enabling Efficient Bispecific and Complex Multispecific Antibody Generation

Enabling high-purity assembly without complex purification to support rapid format exploration of multispecifics
Graph showing variation in Raji cell killing with increasing bispecific antibody concentration for a variety of bispecifics loading="lazy">
Wed 3 Jun 2026
White papers

Discovery and Engineering of T Cell Engagers (TCEs) using Adimab’s Platform

Systematic TCE exploration using tunable CD3/CD28 panels and rapid format screening optimizes efficacy
Resources